Product Information
POSACONAZOLE DR 100 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $2.0315 per EA under NDC 70748025807. Its NADAC has been published 291 times since Mar 10, 2021.
FDA first approved this application on Feb 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748025807
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POSACONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA213454FDA Approved
2/1/2021
TE Code
AB
On Market Since
2/17/2021
Pharmacological Classes
Price Statistics
The NADAC for POSACONAZOLE DR 100 MG TABLET has been published 291 times since Mar 10, 2021, and over the history we have for it it has declined 94.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0315 per EA |
|---|---|
| All-time high | $35.8342 (May 12, 2021) |
| All-time low | $1.9969 (Aug 19, 2026) |
| 52-week high | $3.7685 |
| 52-week low | $1.9969 |
| Median price | $6.5842 |
| Average price | $10.3893 |
| Largest weekly change | -49.9% (Oct 19, 2022) |
| Weeks tracked | 291 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
POSACONAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POSACONAZOLE DR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POSACONAZOLE DR 100 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $2.0315 per EA (NDC 70748025807), effective Sep 30, 2026.
How has the price of POSACONAZOLE DR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for POSACONAZOLE DR 100 MG TABLET has declined 94.3%. It has been tracked across 291 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for POSACONAZOLE DR 100 MG TABLET?
Since Mar 10, 2021, the NADAC for POSACONAZOLE DR 100 MG TABLET has ranged from a low of $1.9969 (Aug 19, 2026) to a high of $35.8342 (May 12, 2021), with a median of $6.5842 per EA.
Are there cheaper alternatives to POSACONAZOLE DR 100 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POSACONAZOLE DR 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures POSACONAZOLE DR 100 MG TABLET?
POSACONAZOLE DR 100 MG TABLET (NDC 70748025807) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.